| Progression of Parkinson’s disease pathology is reproduced by intragastric administration of rotenone in mice F Pan-Montojo, O Anichtchik, Y Dening, L Knells, S Pursche, R Jung, ... Nature Precedings, 1-1, 2010 | 603 | 2010 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10285), 1637-1645, 2021 | 576* | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 484* | 2021 |
| SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson’s disease P Garcia-Reitböck, O Anichtchik, A Bellucci, M Iovino, C Ballini, ... Brain 133 (7), 2032-2044, 2010 | 340 | 2010 |
| Neurochemical and behavioural changes in zebrafish Danio rerio after systemic administration of 6‐hydroxydopamine and 1‐methyl‐4‐phenyl‐1,2,3,6 … OV Anichtchik, J Kaslin, N Peitsaro, M Scheinin, P Panula Journal of neurochemistry 88 (2), 443-453, 2004 | 245 | 2004 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 215 | 2022 |
| Loss of PINK1 function affects development and results in neurodegeneration in zebrafish O Anichtchik, H Diekmann, A Fleming, A Roach, P Goldsmith, ... Journal of Neuroscience 28 (33), 8199-8207, 2008 | 206 | 2008 |
| Alpha‐synuclein in peripheral tissues and body fluids as a biomarker for P arkinson's disease–a systematic review N Malek, D Swallow, KA Grosset, O Anichtchik, M Spillantini, DG Grosset Acta Neurologica Scandinavica 130 (2), 59-72, 2014 | 199 | 2014 |
| Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy JO Rinne, OV Anichtchik, KS Eriksson, J Kaslin, L Tuomisto, H Kalimo, ... Journal of neurochemistry 81 (5), 954-960, 2002 | 168 | 2002 |
| An altered histaminergic innervation of the substantia nigra in Parkinson's disease OV Anichtchik, JO Rinne, H Kalimo, P Panula Experimental neurology 163 (1), 20-30, 2000 | 160 | 2000 |
| Modulation of the histaminergic system and behaviour by α‐fluoromethylhistidine in zebrafish N Peitsaro, J Kaslin, OV Anichtchik, P Panula Journal of neurochemistry 86 (2), 432-441, 2003 | 144 | 2003 |
| Hyperserotonergic phenotype after monoamine oxidase inhibition in larval zebrafish V Sallinen, M Sundvik, I Reenilä, N Peitsaro, D Khrustalyov, O Anichtchik, ... Journal of neurochemistry 109 (2), 403-415, 2009 | 138 | 2009 |
| Distribution and modulation of histamine H3 receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease OV Anichtchik, N Peitsaro, JO Rinne, H Kalimo, P Panula Neurobiology of disease 8 (4), 707-716, 2001 | 128 | 2001 |
| Alcohol-histamine interactions. SM Zimatkin, OV Anichtchik Alcohol and alcoholism (Oxford, Oxfordshire) 34 (2), 141-147, 1999 | 127 | 1999 |
| Distinct structure and activity of monoamine oxidase in the brain of zebrafish (Danio rerio) O Anichtchik, V Sallinen, N Peitsaro, P Panula Journal of Comparative Neurology 498 (5), 593-610, 2006 | 114 | 2006 |
| Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson’s disease model M Wegrzynowicz, D Bar-On, L Calo’, O Anichtchik, M Iovino, J Xia, ... Acta Neuropathologica 138, 575-595, 2019 | 99 | 2019 |
| Decreased BDNF levels are a major contributor to the embryonic phenotype of huntingtin knockdown zebrafish H Diekmann, O Anichtchik, A Fleming, M Futter, P Goldsmith, A Roach, ... Journal of Neuroscience 29 (5), 1343-1349, 2009 | 97 | 2009 |
| Identification of zebrafish histamine H1, H2 and H3 receptors and effects of histaminergic ligands on behavior N Peitsaro, M Sundvik, OV Anichtchik, J Kaslin, P Panula Biochemical pharmacology 73 (8), 1205-1214, 2007 | 97 | 2007 |
| Endogenous alpha-synuclein influences the number of dopaminergic neurons in mouse substantia nigra P Garcia-Reitboeck, O Anichtchik, JW Dalley, N Ninkina, GK Tofaris, ... Experimental neurology 248, 541-545, 2013 | 84 | 2013 |
| Modulation of histamine H3 receptors in the brain of 6‐hydroxydopamine‐lesioned rats OV Anichtchik, M Huotari, N Peitsaro, JW Haycock, PT Männistö, ... European Journal of Neuroscience 12 (11), 3823-3832, 2000 | 80 | 2000 |
